Longer QRS Duration Predicts Cardiac Death, Heart Attack

This article originally appeared here.
Share this content:
Longer QRS Duration Predicts Cardiac Death, Heart Attack
Longer QRS Duration Predicts Cardiac Death, Heart Attack

MONDAY, Oct. 19, 2015 (HealthDay News) -- Longer QRS duration predicts cardiac death and nonfatal myocardial infarction (MI) in patients with coronary artery disease, according to a study published in the Nov. 1 issue of The American Journal of Cardiology.

Roy Huurman, from Erasmus Medical Center in the Netherlands, and colleagues investigated the long-term prognostic value of QRS duration in 512 patients (308 men) with known or suspected coronary artery disease who underwent myocardial perfusion imaging (MPI).

The researchers found that over a mean follow-up of 8.6 years, 290 patients died (60 percent), with 27 percent of these deaths attributable to cardiac causes. Twenty-eight patients (6 percent) had nonfatal MI, and 127 patients (25 percent) underwent late coronary revascularization (>three months). The annualized cardiac death rates and cardiac death or nonfatal MI rates were lower in patients with QRS duration <120 ms compared with those with QRS duration of ≥120 ms (2.2 percent and 2.3 percent, respectively, versus 4.1 percent and 4.4 percent, respectively). In multivariate models, QRS duration ≥120 ms was an independent predictor of both end points, in addition to clinical characteristics and MPI results.

"In conclusion, QRS duration ≥120 ms is an independent predictor of cardiac death and cardiac death or nonfatal MI, after adjustment for clinical characteristics and MPI results," write the authors.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Many Foster Kids Inappropriately Prescribed Psychiatric Drugs

Many Foster Kids Inappropriately Prescribed Psychiatric Drugs

Some children may be getting meds they don't need, others may be going without drugs that may help

FDA Approves Device for Acute Coronary Artery Perforations

FDA Approves Device for Acute Coronary Artery Perforations

The PK Papyrus device is a balloon-expandable covered coronary stent and delivery system

Decrease in Infant Walker-Related Injuries Since 2010

Decrease in Infant Walker-Related Injuries Since 2010

Decrease in injuries following implementation of federal mandatory safety standard in 2010

is free, fast, and customized just for you!




Already a member?

Sign In Now »